New Product Release: Nitazenes Array is now available on the Evidence MultiSTAT. Find out more here

[mpc_image image=”9200″ image_size=”full” force_fullwidth=”true” image_opacity=”100″ image_inner_border_gap=”0″ effect=”none” image_hover_opacity=”100″]

Nitazenes

The emergence of nitazenes, a powerful new class of synthetic opioids, has created a major challenge for healthcare and law enforcement. These substances are often hundreds of times stronger than morphine and are missed by traditional drug screening methods.

First To Market
The only product on the market
that can test for nitazenes in
urine in <20 minutes.

Keep Communities Safe
Our rapid results allow you to get
information out quickly to local
authorities and public health.

Highly Accurate Results
Biochip results are comparable to
confirmatory testing, providing you with reliable results you can trust.

Fully Automated Ease of Use
The Evidence MultiSTAT is a fully
automated analyser; simply load the
sample and press start.

Large Detection Range
Detect up to 10 different nitazenes
and their metabolites due to our
assay cross-reactivity.

Catalogue Number: EV4658

Analogues Detected

Nitazenes
IsotonitazeneEtonitazeneProtonitazene
ClonitazeneN-Pyrrolidino EtonitazeneN-Pyrrolidino Metonitazene
MetonitazeneN-Desethyl IsotonitazeneButonitazene
N-Pyrrolidino Protonitazene--

Why Nitazenes Testing Matters

Detection Challenges

Detection Challenges

Standard opioid tests do not detect nitazenes.

Until now, testing required advanced techniques such as LC-MS/MS.

Emerging Threat

Emerging Threat

Increasingly found in post-mortem toxicology cases.

Often mixed with other drugs like fentanyl, heroin, or counterfeit pills.

Global Spread

Global Spread

Detected in Europe, North America, Asia, and South America.

The UK recorded 400 nitazene-related deaths between June 2023 and January 2025.

In the U.S., 320 overdose deaths in 2023 reportedly involved nitazenes, according to the World Drug Report. However, this number is likely understated.

Request Demo